These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 35973380)

  • 21. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome.
    Jarius S; Ruprecht K; Kleiter I; Borisow N; Asgari N; Pitarokoili K; Pache F; Stich O; Beume LA; Hümmert MW; Ringelstein M; Trebst C; Winkelmann A; Schwarz A; Buttmann M; Zimmermann H; Kuchling J; Franciotta D; Capobianco M; Siebert E; Lukas C; Korporal-Kuhnke M; Haas J; Fechner K; Brandt AU; Schanda K; Aktas O; Paul F; Reindl M; Wildemann B;
    J Neuroinflammation; 2016 Sep; 13(1):280. PubMed ID: 27793206
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hope for patients with neuromyelitis optica spectrum disorders - from mechanisms to trials.
    Pittock SJ; Zekeridou A; Weinshenker BG
    Nat Rev Neurol; 2021 Dec; 17(12):759-773. PubMed ID: 34711906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuromyelitis optica spectrum disorder: Pathogenesis, treatment, and experimental models.
    Wu Y; Zhong L; Geng J
    Mult Scler Relat Disord; 2019 Jan; 27():412-418. PubMed ID: 30530071
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Severe disease reactivation in seropositive neuromyelitis optica spectrum disorders patients after stopping eculizumab treatment.
    Sen S; Tuncer A; Terzi M; Bunul SD; Ozen-Acar P; Altunrende B; Ozakbas S; Tutuncu M; Uygunoglu U; Akman-Demir G; Karabudak R; Efendi H; Siva A
    Mult Scler Relat Disord; 2023 Nov; 79():104949. PubMed ID: 37678131
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Neuromyelitis Optica Spectrum Disorder].
    Misu T
    Brain Nerve; 2021 May; 73(5):475-482. PubMed ID: 34006678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Secreted aminoacyl-tRNA synthetase-interacting multifunctional protein-1 (AIMP1) is a promising predictor for the severity of acute AQP4-IgG positive neuromyelitis optica spectrum disorder.
    Yuan C; Liu X; Cai S; Zhang L; Guo R; Jia Z; Sun Y; Li B
    Mult Scler Relat Disord; 2023 Feb; 70():104504. PubMed ID: 36623394
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Memantine ameliorates motor impairments and pathologies in a mouse model of neuromyelitis optica spectrum disorders.
    Yick LW; Tang CH; Ma OK; Kwan JS; Chan KH
    J Neuroinflammation; 2020 Aug; 17(1):236. PubMed ID: 32782018
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuromyelitis optica, aquaporin-4 antibodies, and neuroendocrine disorders.
    Iorio R; Papi C
    Handb Clin Neurol; 2021; 181():173-186. PubMed ID: 34238456
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuromyelitis Optica (Devic's Syndrome): an Appraisal.
    Crout TM; Parks LP; Majithia V
    Curr Rheumatol Rep; 2016 Aug; 18(8):54. PubMed ID: 27402111
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Satralizumab in the treatment of neuromyelitis optica spectrum disorder.
    Duchow A; Bellmann-Strobl J
    Neurodegener Dis Manag; 2021 Feb; 11(1):49-59. PubMed ID: 33167776
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein IgG associated disorder: A comprehensive neuro-ophthalmic review.
    Sharma J; Bhatti MT; Danesh-Meyer HV
    Clin Exp Ophthalmol; 2021 Mar; 49(2):186-202. PubMed ID: 33426799
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin.
    Jarius S; Ruprecht K; Kleiter I; Borisow N; Asgari N; Pitarokoili K; Pache F; Stich O; Beume LA; Hümmert MW; Trebst C; Ringelstein M; Aktas O; Winkelmann A; Buttmann M; Schwarz A; Zimmermann H; Brandt AU; Franciotta D; Capobianco M; Kuchling J; Haas J; Korporal-Kuhnke M; Lillevang ST; Fechner K; Schanda K; Paul F; Wildemann B; Reindl M;
    J Neuroinflammation; 2016 Sep; 13(1):279. PubMed ID: 27788675
    [TBL] [Abstract][Full Text] [Related]  

  • 33. AQP4-IgG-seronegative patient outcomes in the N-MOmentum trial of inebilizumab in neuromyelitis optica spectrum disorder.
    Marignier R; Pittock SJ; Paul F; Kim HJ; Bennett JL; Weinshenker BG; Wingerchuk DM; Green AJ; Fujihara K; Cutter G; Aktas O; Hartung HP; Drappa J; Ratchford JN; She D; Smith M; Rees W; Cimbora D; Katz E; Cree BAC;
    Mult Scler Relat Disord; 2022 Jan; 57():103356. PubMed ID: 35158465
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuromyelitis optica spectrum disorders: a review with a focus on children and adolescents.
    Paolilo RB; Paz JAD; Apóstolos-Pereira SL; Rimkus CM; Callegaro D; Sato DK
    Arq Neuropsiquiatr; 2023 Feb; 81(2):201-211. PubMed ID: 36948203
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pediatric Neuromyelitis Optica Spectrum Disorder.
    Poisson K; Moeller K; Fisher KS
    Semin Pediatr Neurol; 2023 Jul; 46():101051. PubMed ID: 37451749
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autoimmune AQP4 channelopathies and neuromyelitis optica spectrum disorders.
    Hinson SR; Lennon VA; Pittock SJ
    Handb Clin Neurol; 2016; 133():377-403. PubMed ID: 27112688
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overlap syndrome of anti-aquaporin 4 positive neuromyelitis optica spectrum disorder and primary Sjögren's syndrome: a systematic review of individual patient data.
    Prasad CB; Kopp CR; Naidu G; Sharma V; Misra DP; Agarwal V; Sharma A
    Rheumatol Int; 2024 Dec; 44(12):2807-2815. PubMed ID: 37500817
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A multi-facet comparative analysis of neuromyelitis optica spectrum disorders in patients with seropositive and seronegative AQP4-IgG.
    Wang X; Chen X; Zhu C; Ma H; Wang F; Qin L; Li W
    Medicine (Baltimore); 2018 Nov; 97(48):e13100. PubMed ID: 30508889
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural and visual functional deficits in a rat model of neuromyelitis optica spectrum disorders related optic neuritis.
    Zhang Y; Bao Y; Qiu W; Peng L; Fang L; Xu Y; Yang H
    Exp Eye Res; 2018 Oct; 175():124-132. PubMed ID: 29913164
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sequential Optic Neuritis: A Neuromyelitis Optica Spectrum Disorder.
    Alam M; Haq MAU; Iqbal A; Ullah K; Nabi D
    J Coll Physicians Surg Pak; 2019 Apr; 29(4):379-380. PubMed ID: 30925966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.